|
|
Post by dreamboatcruise on Feb 12, 2017 14:53:13 GMT -5
I just checked on GlucoWise website and see that they are now stating taking pre-orders in late 2018. I think this is further slip in release date from when I had last looked.
Does anyone know if there are other non-invasive meters that may beat GlucoWise to market?
It seems that could be such a game changer. I think it would be a significantly easier sell to use prandial insulin much earlier in T2 progression by pairing Afrezza, a non-invasive BG meter and a simple dosing protocol based on meter readings.
|
|
|
|
Post by peppy on Feb 12, 2017 17:44:56 GMT -5
I just checked on GlucoWise website and see that they are now stating taking pre-orders in late 2018. I think this is further slip in release date from when I had last looked. Does anyone know if there are other non-invasive meters that may beat GlucoWise to market? It seems that could be such a game changer. I think it would be a significantly easier sell to use prandial insulin much earlier in T2 progression by pairing Afrezza, a non-invasive BG meter and a simple dosing protocol based on meter readings. Gluco wise changed their pre order from fall of 2017 to fall of 2018. No other non invasive glucose monitor I could find. Just looked yesterday. I like the ear lobe idea, ear ring for ladies. (men if they will wear them) the ear lobe full of capillaries. A small radio frequency electrode to send the information to a smart watch or phone.
So much money in this if it can be packaged correctly. Do it.
|
|
|
|
Post by peppy on Feb 13, 2017 8:01:07 GMT -5
I just checked on GlucoWise website and see that they are now stating taking pre-orders in late 2018. I think this is further slip in release date from when I had last looked. Does anyone know if there are other non-invasive meters that may beat GlucoWise to market? It seems that could be such a game changer. I think it would be a significantly easier sell to use prandial insulin much earlier in T2 progression by pairing Afrezza, a non-invasive BG meter and a simple dosing protocol based on meter readings. Gluco wise changed their pre order from fall of 2017 to fall of 2018. No other non invasive glucose monitor I could find. Just looked yesterday. I like the ear lobe idea, ear ring for ladies. (men if they will wear them) the ear lobe full of capillaries. A small radio frequency electrode to send the information to a smart watch or phone.
So much money in this if it can be packaged correctly. Do it.
Looky here. Google has a patent for 'a blood sucking watch'. oh yippee. "Needle free blood draw" That would do it. www.youtube.com/watch?v=hyzCY9VNyyQ the patent shown at the 42 second mark.
If glucowise can do it..... www.gluco-wise.com/
|
|
|
|
Post by dreamboatcruise on Feb 13, 2017 14:14:33 GMT -5
Gluco wise changed their pre order from fall of 2017 to fall of 2018. No other non invasive glucose monitor I could find. Just looked yesterday. I like the ear lobe idea, ear ring for ladies. (men if they will wear them) the ear lobe full of capillaries. A small radio frequency electrode to send the information to a smart watch or phone.
So much money in this if it can be packaged correctly. Do it.
Looky here. Google has a patent for 'a blood sucking watch'. oh yippee. "Needle free blood draw" That would do it. www.youtube.com/watch?v=hyzCY9VNyyQ the patent shown at the 42 second mark.
If glucowise can do it..... www.gluco-wise.com/
There was a company trying to develop the reverse of this... needle free injection. As I recall it was using electrical potential and imparting a charge to drive the fluids through the skin (take with grain of salt as purely from memory). It ended up causing significant skin irritation for many, and I believe they discontinued development. This seems like it may be similar technology and may have similar side effects. Also seems that the watch would need some disposable component if it is using blood for the readings. The Glucowise type technology seems a far superior solution, IF it is accurate enough to be used for dosing insulin. It's too bad they have apparently had setback of a year. Wish there was some additional info about why that happened. If I had to guess, I'd think this is indication that the technology really hasn't reached an appropriate level of accuracy. |
|
|
|
Post by peppy on Feb 13, 2017 14:29:23 GMT -5
I think the secret of the watch is that it has a charge, the I watch.
The charge on the watch may help with heat it could help move the blood in the capillaries. Additionally the charge to provide the energy for the calculation.
The oxygen saturation of hemoglobin can be measured with a pulse oximeter..
heckoli, measure the glucose saturation of hemoglobin you have a HgA1c.
Do it!
that watch was being shown upside down on the wrist, blood vessel rich.
|
|
|
|
Post by sayhey24 on Feb 13, 2017 19:30:18 GMT -5
Dexcom gave Verily $100M to develop a non-invasive CGM. The last I checked the target release date was 2022. I think it is based on the non-invasive bandage CGM developed at UCSD. When I met with San Meditech they told me they already had a non-invasive CGM but I never saw it. Whether they do, who knows but they do have an awesome CGM with a tiny needle and great wireless. To be honest the Libre may not be non-invasive but for use by diabetics its pretty close, its cheap, better than poking your finger and available today. Its all MNKD needs to sell afrezza today. The end goal of the non-invasive for general use would be to integrated with a fitbit type device so you get heart rate and glucose levels.
|
|
|
|
Post by peppy on Feb 13, 2017 19:37:53 GMT -5
Dexcom gave Verily $100M to develop a non-invasive CGM. The last I checked the target release date was 2022. I think it is based on the non-invasive bandage CGM developed at UCSD. When I met with San Meditech they told me they already had a non-invasive CGM but I never saw it. Whether they do, who knows but they do have an awesome CGM with a tiny needle and great wireless. To be honest the Libre may not be non-invasive but for use by diabetics its pretty close, its cheap, better than poking your finger and available today. Its all MNKD needs to sell afrezza today. The end goal of the non-invasive for general use would be to integrated with a fitbit type device so you get heart rate and glucose levels. quote: I think it is based on the non-invasive bandage CGM developed at UCSD. reply: www.cnbc.com/2015/01/15/a-tattoo-may-end-fingerpricks-for-diabetics.html They called it a rub on Tattoo. two electrodes and an enzyme.
|
|
|
|
Post by sayhey24 on Feb 14, 2017 6:40:47 GMT -5
Dexcom gave Verily $100M to develop a non-invasive CGM. The last I checked the target release date was 2022. I think it is based on the non-invasive bandage CGM developed at UCSD. When I met with San Meditech they told me they already had a non-invasive CGM but I never saw it. Whether they do, who knows but they do have an awesome CGM with a tiny needle and great wireless. To be honest the Libre may not be non-invasive but for use by diabetics its pretty close, its cheap, better than poking your finger and available today. Its all MNKD needs to sell afrezza today. The end goal of the non-invasive for general use would be to integrated with a fitbit type device so you get heart rate and glucose levels. quote: I think it is based on the non-invasive bandage CGM developed at UCSD. reply: www.cnbc.com/2015/01/15/a-tattoo-may-end-fingerpricks-for-diabetics.html They called it a rub on Tattoo. two electrodes and an enzyme.
Thanks - thats a good picture of it. As I mentioned when compared to the Libre, how much value is it? For right now the Libre is cheap and its pretty small and good. I think an even smaller version of the Libre, maybe dime sized, with Bluetooth is all that is needed for the PWDs. Until they can get it in a fitbit the general public won't be wearing them anyway. |
|
|
|
Post by peppy on Feb 14, 2017 7:07:16 GMT -5
the libre is crazy is this regard, call your physicians office for consultation to see the readings.
what the heck o ly is that about?
It will not do any good for the usa patient used this way.
Controlled data.
|
|
|
|
Post by dreamboatcruise on Feb 14, 2017 10:40:09 GMT -5
I saw a reference in a post on one of the diabetes community sites that said the real-time (non pro) version of the Freestyle Libra might be coming to U.S. in 2017.
Apparently I don't know where to look up submission for medical devices on FDA site. The database I found for PMAs seems to only list ones that are approved but not those submitted. Does someone know where to look that up and if there is some decision date?
It may well be that insurance coverage would still take a long time. The "pro" version is probably covered differently since it would be considered a diagnostic test done by the doctor... and doubtfully for extended periods of time since it would require doctor visits every two weeks. The patient version would be significant expense for insurance since it is more expensive than test strips... and as I understand it, wouldn't totally negate the need for patients to use test strips to double check since Libra is not as accurate as test strips.
|
|
|
|
Post by compound26 on Feb 14, 2017 11:06:53 GMT -5
I saw a reference in a post on one of the diabetes community sites that said the real-time (non pro) version of the Freestyle Libra might be coming to U.S. in 2017. Apparently I don't know where to look up submission for medical devices on FDA site. The database I found for PMAs seems to only list ones that are approved but not those submitted. Does someone know where to look that up and if there is some decision date? It may well be that insurance coverage would still take a long time. The "pro" version is probably covered differently since it would be considered a diagnostic test done by the doctor... and doubtfully for extended periods of time since it would require doctor visits every two weeks. The patient version would be significant expense for insurance since it is more expensive than test strips... and as I understand it, wouldn't totally negate the need for patients to use test strips to double check since Libra is not as accurate as test strips. Hopefully the coverage will be better than the coverage for Dexcom. As I understand it, Freestyle Libra will be much cheaper than Dexcom. Per Matt B, "The Dexcom G6 coming in 2017 sounds like it might be a great (but expensive) alternative to the Libre.". afrezzadownunder.com/2015/09/freestyle-libre-update/ |
|
|
|
Post by dreamboatcruise on Feb 14, 2017 11:37:19 GMT -5
I saw a reference in a post on one of the diabetes community sites that said the real-time (non pro) version of the Freestyle Libra might be coming to U.S. in 2017. Apparently I don't know where to look up submission for medical devices on FDA site. The database I found for PMAs seems to only list ones that are approved but not those submitted. Does someone know where to look that up and if there is some decision date? It may well be that insurance coverage would still take a long time. The "pro" version is probably covered differently since it would be considered a diagnostic test done by the doctor... and doubtfully for extended periods of time since it would require doctor visits every two weeks. The patient version would be significant expense for insurance since it is more expensive than test strips... and as I understand it, wouldn't totally negate the need for patients to use test strips to double check since Libra is not as accurate as test strips. Hopefully the coverage will be better than the coverage for Dexcom. As I understand it, Freestyle Libra will be much cheaper than Dexcom. Per Matt B, "The Dexcom G6 coming in 2017 sounds like it might be a great (but expensive) alternative to the Libre.". afrezzadownunder.com/2015/09/freestyle-libre-update/Though I would expect that insurers will view Libra in the light of being a more expensive option to test strips rather than as a cheaper version of Dexcom that they largely aren't now covering. At least one would expect coverage similar or somewhat better than Dexcom. Article on Diatribe from Nov 2016 states that G6 isn't coming until 2018. Matt's mention of 2017 is likely outdated since it was made over a year prior to that. G6, GlucoWise, Verily, etc... looks like Freestyle Libra will be the only new BG reading technology the U.S. will get in 2017... hopefully it will be first half of 2017 rather than later. but it seems things always seem to take longer than expected. |
|
